PULMONARY TUBERCULOSIS
Clinical trials for PULMONARY TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new PULMONARY TUBERCULOSIS trials appear
Sign up with your email to follow new studies for PULMONARY TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AI-Designed TB treatment could boost cure rates and cut side effects
Disease control Not yet recruitingThis study tests a new two-drug combination for tuberculosis (TB) designed by artificial intelligence. The goal is to see if it works better and causes fewer liver problems than the standard four-drug regimen. About 200 adults with newly diagnosed, drug-sensitive TB will take eit…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: Ministry of Health, Saudi Arabia • Aim: Disease control
Last updated May 17, 2026 07:52 UTC
-
New 9-Month pill combo could beat Drug-Resistant TB
Disease control Not yet recruitingThis study tests a 9-month, all-oral drug combination (BLMZ) for people with rifampicin-resistant tuberculosis (TB). About 120 participants aged 12 and older will take the pills and be followed for 24 months to see if the infection clears and stays gone. The goal is to find a sho…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE3 • Sponsor: Beijing Chest Hospital • Aim: Disease control
Last updated May 15, 2026 11:57 UTC